Oncorena treatment for renal cancer
Oncorena has raised $14.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Oncorena's investors include HealthCap, Linc, Fåhraeus Startup and Growth, Partners for Development investments in Life Sciences.
Oncorena is headquartered in Lund, Sweden.
Oncorena treatment for renal cancer
Oncorena is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncorena — Funding & Investors." VCBacked, June 26, 2025, https://www.vcbacked.co/company/oncorena. Accessed August 16, 2026.
VCBacked. (2025). Oncorena — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/oncorena
{{cite web |title=Oncorena — Funding & Investors |url=https://www.vcbacked.co/company/oncorena |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated